The Final Frontier: Brain Healthtech — Treatment, Prevention & BCI
Join us for a focused, 90-minute private briefing showcasing three pioneering U.S. companies operating across the core pillars of the neuro-revolution: Treatment, Prevention, and Brain-Computer Interfaces.
Hosted by TradeMission.org
An official Certified Trade Mission Partner with the U.S. Department of Commerce, dedicated to bridging international capital with premier American innovation. Over 100 global missions connecting foreign capital investors directly with market-leading U.S. companies.
Co-hosted by Jewelake Management (Jewelake.com)
Featured Presenters
1. TrueBinding | Treatment & Commercial Traction
The Technology: Novel biotherapeutic targeting neurodegenerative disease through an active Expanded Access Program (EAP).
Market Traction: Already adopted and prescribed by 200+ physicians across the United States.
Investment Angle: Early commercial validation and physician adoption addressing massive unmet needs in Alzheimer’s treatment.
2. Sinaptica | Alzheimer's Treatment & Brain Health/Memory
The Technology: Precision neuromodulation focused on memory enhancement and slowing cognitive decline before irreversible damage occurs.
Market Traction: Shifting the paradigm from reactive "sick care" to proactive neuro-preservation with 2 newly received CPT reimbursement codes.
Investment Angle: Direct exposure to the rapid-growth longevity and cognitive wellness sector for an aging global population.
3. Paradromics | Brain-Computer Interface (BCI)
The Technology: High-bandwidth, direct neural interface platform advancing toward clinical trials to restore communication and motor control.
Market Traction: Clinical trials underway, with successful first-human implantation and demonstrated real-time speech decoding, supported by leading U.S. medical centers and a strategic collaboration with Siemens Healthineers.
Investment Angle: High-moat, IP-heavy platform technology bridging severe neurological rehabilitation with long-term human-machine interface applications.
Agenda
Time Segment Focus
Welcome & Opening Remarks Framing the Neuro-Revolution
TrueBinding 20-min Presentation + 10-min Q&A
Sinaptica 20-min Presentation + 10-min Q&A
Paradromics 20-min Presentation + 10-min Q&A
Interactive Discussion & Wrap-up Closing insights & direct investor follow-ups
Event Details
Format: Online Seminar via Google Meet (link sent upon approval)
Date & Time:
U.S. (PDT): Wednesday, 21 October | 8:00 PM – 9:30 PM
Asia (SGT / HKT): Thursday, 22 October | 11:00 AM – 12:30 PM
Who Should Attend: Institutional investors, family offices, sovereign wealth representatives, and strategic cross-border venture funds targeting frontier healthtech, biotech, and neuro-innovations.